India: Tata Chemicals Launches Pharma Grade Sodium Bicarbonate
Tata Chemicals, the country’s leading producer of soda ash and sodium bicarbonate, has launched Medikarb, India’s first branded pharmaceutical grade sodium bicarbonate. It will be manufactured in FDA-certified facilities that are compliant with GMP (Good Manufacturing Practice) standards to ensure high quality conforming to the Indian Pharmacopoeia specifications, the company said.
Mr. Sanjiv Lal, Chief Operating Officer, India Chemicals Operations, Tata Chemicals, said the branded sodium bicarbonate is suitable for use as an API and in pharma formulations. It will be available through the company’s distributor network, he added. With an annual capacity of 100,000 tonnes in India, Tata Chemicals also has two other sodium bicarbonate brands – Sodakarb, customised for use as a food additive and Alkakarb, for use in animal feed.
You May Interested In
SS-31 Cosmetic peptides, discounted price improving cognitive impairment factory supply
$8E+1/UNIT FOB
2026-09-13
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
First New UV Filter in Nearly 27 Years: BASF's Tinosorb® S Approved by FDA, Marking a Historic Shift for the U.S. Sunscreen Market
-
India's PV Community Comes Together at the 6th Edition Drug Safety Symposium 2026 – India Chapter to Shape the Future of Patient Safety
-
China’s Hybio Takes Generic Tirzepatide to FDA: Lilly’s GLP-1 Fortress Gets a Warning Shot
-
FDA approves bemotrizinol, a long-used UV filter, for U.S. sunscreens
-
FDA delays proposal to ban formaldehyde in hair straighteners
-
Can Florida's Authorization to Import Prescription Drugs from Canada Lower Medication Prices?
-
FDA Releases New Resources for Food Traceability Final Rule Compliance
-
IFSAC Unveils 2021 Report: Diverse Food Sources Linked to Salmonellosis Cases
-
FDA to Nationwide Ban Brominated Vegetable Oil (BVO) in Food
-
FDA Issues Warning to Produce Importer for Non-Compliance
Recommend Reading
-
![Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger]()
Medicare’s $50 GLP-1 Door Opens: Weight-Loss Drug Demand Just Got Bigger
-
![Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire]()
Refrigerant Prices Peak! Domestic Quotas Tighten, U.S. and U.K. Policies Add Fuel to the Fire
-
![FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center]()
FDA Names Veteran Oncology Regulator Pazdur as Director of Drug Review Center
-
![A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization]()
A Fake Email Drains RMB 12 Million: Asia’s Waterproof Giant’s Overseas ‘Payment Heist’ Exposes the Fatal Blind Spot of Chinese Corporate Globalization
-
![Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm]()
Pesticide Market in Limbo: Prices Plunge Amid Weak Demand and Overcapacity—Only a Few Hold Firm
-
![Applications of Diphenyl Cyanide]()
Applications of Diphenyl Cyanide
-
![Chemical Properties of Dibenzylideneacetone]()
Chemical Properties of Dibenzylideneacetone
-
![Downstream Demand Releases, Formic Acid Prices Steadily Rise]()
Downstream Demand Releases, Formic Acid Prices Steadily Rise
-
![China’s EVA Market to Experience Volatile Decline in 2025, with Supply Intensifying in 2026 and Demand Remaining Stable but Weak]()
China’s EVA Market to Experience Volatile Decline in 2025, with Supply Intensifying in 2026 and Demand Remaining Stable but Weak
-
![Natural Rubber Prices Fluctuated Downward in 2025, Bottom Support Exists in 2026 with a Slight Shift Upward in Price Focus]()
Natural Rubber Prices Fluctuated Downward in 2025, Bottom Support Exists in 2026 with a Slight Shift Upward in Price Focus
